Revolutionizing Health Monitoring: Withings' New Smart Scale
At the recently concluded CES 2026 in Las Vegas, Withings unveiled its latest innovation, the Body Scan 2, a smart scale designed to offer comprehensive health assessments, including hypertension risk and cardiac efficiency. This groundbreaking device promises to revolutionize personal health monitoring, particularly in North East India and beyond.
Detailed Health Readings
The Body Scan 2, a second-generation smart scale, measures more than 60 biomarkers in just 90 seconds. This is significantly more than what an average smart ring or smartwatch can collect in weeks. The scale uses Impedance Cardiography (ICG) and 6-lead ECG to measure cardiac efficiency, cardiac reactivity, ECG, and heart age. Its proprietary AI model assesses a user's hypertension risk and potential risk of glycemic dysregulation. The scale's pulse wave velocity function measures arterial stiffness, providing a detailed picture of one's cardiovascular health.
Hypertension Management in North East India
Hypertension, often referred to as the "silent killer," affects millions of people worldwide, including a significant number in North East India. With the increasing prevalence of lifestyle diseases, the Body Scan 2's ability to monitor and assess hypertension risk could prove invaluable. By making health monitoring more accessible and convenient, the smart scale could help in early detection and management of hypertension, potentially reducing the burden on healthcare systems in the region.
Value During Periods of Imbalance
The Body Scan 2 app provides insights and recommendations for the reversal of problematic biomarkers. This guidance is particularly useful during periods of cardiometabolic imbalance, such as chronic stress, a sedentary lifestyle, weight gain or loss, or menopause and perimenopause. By offering personalized advice, the smart scale could empower individuals to take control of their health and make informed decisions about their lifestyle choices.
Availability and Pricing
Pending FDA clearance for the aforementioned metrics, the Body Scan 2 will ship in Q2 of 2026 and retail for $600 in the US. Although it comes with a premium price tag, the comprehensive health assessments and personalized guidance it offers could prove to be a worthwhile investment for those seeking to prioritize their health.
A New Era of Health Monitoring
With the launch of the Body Scan 2, Withings is ushering in a new era of health monitoring. By providing detailed health readings and personalized guidance, the smart scale could revolutionize the way individuals manage their health, particularly in North East India and other regions with a high prevalence of lifestyle diseases. As technology continues to evolve, we can expect to see more innovations like the Body Scan 2 that make health monitoring more accessible and convenient for all.